WHAT WE DO

WHAT IS A Regulatory Gap Analysis?

A Regulatory Gap Analysis is a structured review of your existing documentation, evidence and regulatory processes against applicable regulatory requirements.

It provides an objective assessment of where your product, technical documentation or quality system currently stands, identifying areas that are complete, partially complete or missing altogether.

The result is a clear understanding of what work remains before progressing towards regulatory submission, certification or market access.

Regulatory requirements can be complex and continually evolving. Without a clear understanding of what is required, organisations can invest significant time and resources developing documentation, generating evidence or implementing processes that may not fully meet regulatory expectations.

A Gap Analysis helps identify potential issues early, reducing the risk of delays, unnecessary rework and unexpected findings during regulatory review.

By understanding your current position, you can focus resources on the areas that will have the greatest impact on regulatory readiness.

A Gap Analysis can be valuable at many stages of product development and commercialisation.

Organisations often undertake a Gap Analysis before preparing technical documentation, before engaging with a notified body or approved body, following significant regulatory changes, or when preparing to enter a new market.

It can also be useful following acquisitions, product modifications or organisational changes to ensure existing documentation and processes remain aligned with current regulatory expectations.

The scope of a Gap Analysis can be tailored to the specific needs of the organisation.

Depending on the objectives, this may include:

  • Regulatory strategy and pathway
  • Technical documentation
  • Clinical or performance evidence
  • Risk management documentation
  • Quality management systems
  • Post-market surveillance activities
  • Product claims and intended purpose
  • Labelling and information supplied with the device

The output is typically a prioritised assessment highlighting the areas requiring further development and recommendations for addressing identified gaps.

A Gap Analysis is not simply a compliance checklist.

The greatest value comes from understanding which gaps present the highest level of risk and developing a proportionate plan to address them. By prioritising activities and establishing clear next steps, organisations can make informed decisions about resource allocation, development priorities and regulatory strategy.

This approach helps create a practical roadmap towards regulatory readiness rather than generating a list of findings with no clear route forward.

Our regulatory specialists conduct tailored Gap Analyses for medical devices, in vitro diagnostics and digital health technologies. We work closely with clients to understand their technology, intended purpose, target markets and current stage of development before assessing documentation and evidence against applicable requirements.

Our reviews provide practical, prioritised recommendations designed to support decision-making, reduce regulatory risk and establish a clear pathway towards compliance and market access.

HOW WE HELP

WHY CHOOSE MEDILINK SPECIALIST CONSULTANCY?

Sector Expertise

Our team brings extensive experience across MedTech, diagnostics, digital health and life sciences. Combining regulatory, clinical, innovation and commercialisation expertise, we provide practical guidance tailored to the specific challenges of highly regulated healthcare markets.

End-to-End Support

From early-stage innovation and evidence generation through to regulatory approval, market access and commercialisation, we provide connected support throughout the product lifecycle. Our multidisciplinary approach ensures technical, regulatory and commercial considerations are aligned from the outset.

Trusted Industry Partner

As part of Medilink’s established healthcare and life sciences network, we work closely with innovators, manufacturers, NHS organisations, universities and investors. Our independent, objective advice helps organisations make informed decisions with confidence.